Gene: NRBP2
Official Full Name: nuclear receptor binding protein 2provided by HGNC
Gene Summary: Predicted to enable protein serine/threonine kinase activity. Involved in negative regulation of macroautophagy. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO15631 | NRBP2 Knockout cell line (HeLa) | Human | NRBP2 | 1:3~1:6 | Negative | Online Inquiry |
KO15632 | NRBP2 Knockout cell line (HCT 116) | Human | NRBP2 | 1:2~1:4 | Negative | Online Inquiry |
KO15633 | NRBP2 Knockout cell line (HEK293) | Human | NRBP2 | 1:3~1:6 | Negative | Online Inquiry |
KO15634 | NRBP2 Knockout cell line (A549) | Human | NRBP2 | 1:3~1:4 | Negative | Online Inquiry |
NRBP2 Gene Knockout Cell Lines are innovative biological tools designed specifically for research into the NRBP2 gene, which plays a crucial role in cellular signaling and various physiological processes. These cell lines have been engineered using advanced CRISPR/Cas9 genome editing technology to create precise and targeted deletions of the NRBP2 gene, allowing researchers to study the resultant phenotypic changes and elucidate the gene's functional roles in health and disease.
The primary function of NRBP2 Gene Knockout Cell Lines centers around their ability to enable detailed investigations into NRBP2-related pathways. By knocking out this gene, researchers can assess its impact on cellular mechanisms such as growth regulation, apoptosis, and signaling cascades. This is invaluable in understanding the molecular basis of diseases where NRBP2 is implicated, such as certain cancers and metabolic disorders. Additionally, these cell lines serve as a platform for drug discovery, permitting the screening of therapeutic agents that target pathways modulated by NRBP2.
Scientifically, these cell lines hold significant importance in both academic and clinical research settings. They facilitate a deeper understanding of cellular mechanisms and offer a means to validate potential therapeutic targets. Furthermore, the wealth of data generated from experiments utilizing NRBP2 Knockout models can contribute to the development of biopharmaceuticals aimed at mitigating conditions associated with altered NRBP2 function.
What sets NRBP2 Gene Knockout Cell Lines apart from other cell lines is their high specificity and efficiency in gene modification, coupled with the extensive background data provided for each line. Unlike generic knockout models, these cell lines are optimized for reproducibility and reliability in experimental outcomes, minimizing off-target effects and maximizing the biological relevance of findings.
For researchers and clinicians looking to delve into the nuances of cellular behavior influenced by NRBP2, these knockout cell lines are indispensable. They empower users to conduct high-caliber research that translates into meaningful insights and practical applications in biomedicine. Trust our expertise in advanced genetic technologies to provide you with the highest quality cell lines, designed to elevate your research and clinical endeavors to new heights.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.